For decades, hormone replacement therapy (HRT) for women was sidelined amid safety concerns. Now, as research clarifies benefits and risks, and patient demand grows, a related trend is taking hold: testosterone supplementation. While social media promotes testosterone as a libido booster for women, the reality is more nuanced.
The Science Behind Female Testosterone
Women naturally produce testosterone, albeit at roughly one-tenth the level of men. Yet, this hormone is far from insignificant. Obstetrician-gynecologist Jill Liss emphasizes that testosterone plays a crucial role in female sexual function, alongside estrogen and progesterone. Studies confirm that testosterone, delivered through creams or gels, can increase sexual desire, arousal, and responsiveness in women.
Who Benefits from Testosterone?
Experts caution against indiscriminate use. The 2019 Global Consensus Position Statement recommends testosterone only for postmenopausal women with clinically diagnosed hypoactive sexual desire disorder (HSDD). Guidelines now extend to women in their late reproductive years who are not at risk of pregnancy, as testosterone exposure can masculinize developing fetuses. Dosage is critical: treatment should maintain hormone levels within the normal female range.
Beyond Libido: Risks and Limitations
Testosterone declines in women can begin as early as the 40s, not just during menopause. High doses can cause virilization—a deepening of the voice, increased facial hair, and hair loss—though long-term cardiovascular or cancer risks remain unstudied beyond 24 months. Before testosterone, clinicians should rule out physical, psychological, or social causes of low libido. Estrogen therapy often improves sexual function by alleviating discomfort, making it the first line of treatment.
Regulatory Hurdles and Access
Despite evidence of benefits, testosterone therapy for women faces significant regulatory hurdles in the U.S. A female testosterone patch was rejected by the FDA in 2004 over cardiovascular concerns, even though these risks were not definitively proven. The FDA removed cancer warnings from female HRT in 2023 after a 2002 study was deemed flawed for focusing on older, sicker patients. However, testosterone has suffered guilt by association.
Currently, U.S. women have limited options: online access through physician oversight to an Australian product or off-label prescriptions of male formulations (with careful dosage adjustments). Compounded testosterone is discouraged due to potency variability.
The Bottom Line
Testosterone can be a valuable tool for certain women, but it is not a universal fix. Its effects may be subtle, and the hype surrounding it often outpaces the science. As James Simon of George Washington University notes, testosterone can help, but it is not a shortcut to youth or strength. Ultimately, access remains challenging, even as demand and research continue to grow.
